Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A.P. (Geke) Hospers

Publicaties

A prediction model for response to immune checkpoint inhibition in advanced melanoma

BRAF/MEK inhibitor rechallenge in advanced melanoma patients

Comment on the RAPIDO Trial Point-Counterpoint Debate

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer

Melanoma and microbiota: Current understanding and future directions

The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?

Lees meer

Pers/media

‘Het mooie is dat je het microbioom kunt veranderen’

Darmflora beïnvloedt effectiviteit immunotherapie bij huidkanker

Effectiviteit darmflora beïnvloed immunotherapie bij huidkanker

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients

Lees meer